Impact of gender on safety and efficacy of Rivaroxaban in adolescents & young adults with venous thromboembolism
-
Published:2016-12
Issue:
Volume:148
Page:145-151
-
ISSN:0049-3848
-
Container-title:Thrombosis Research
-
language:en
-
Short-container-title:Thrombosis Research
Author:
Krause Manuela,
Henningsen Anna,
Torge Antje,
Juhl DavidORCID,
Junker Ralf,
Kenet Gili,
Kowalski Dorothee,
Limperger VerenaORCID,
Mesters Rolf,
Anonymous ,
Rocke Angela,
Shneyder Maria,
Clausnizer Hartmut,
Schiesewitz Hanna,
Nowak-Göttl Ulrike
Reference41 articles.
1. Triggers, targets and treatments for thrombosis;Mackman;Nature,2008
2. American College of Chest Physicians. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines;Kearon;Chest,2012
3. American College of Chest Physicians. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines;Ageno;Chest,2012
4. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis;van der Hulle;J. Thromb. Haemost.,2014
5. Indirect comparison of dabigatran, rivaroxaban, Apixaban and edoxaban for the treatment of acute venous thromboembolism;Mantha;J. Thromb. Thrombolysis,2015
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献